Dangerous Drugs
Litigation Update: Developments in the Current Opioid Cases

Litigation Update: Developments in the Current Opioid Cases

In a major development in the ongoing opioid litigation involving the State of New York and Nassau and Suffolk counties, on September 9 defendant manufacturer Endo Pharmaceuticals settled for $50 million. Endo reached the settlement amidst allegations that the company...

Litigation Update: Latest Opioid Litigation Developments

Litigation Update: Latest Opioid Litigation Developments

There have been a number of developments on the opioid litigation front in the last week. Drugmaker Endo Pharmaceuticals and its lawyers from Arnold & Porter are battling allegations that they withheld damaging evidence from the parties by failing to respond to...

Opioid Litigation Update

Opioid Litigation Update

Opening statements in the sprawling opioids trial pursued by the state of New York and Nassau and Suffolk counties against seven defendant manufacturers and suppliers began on June 29 with four hours of presentations. The case is the first one involving opioids to be...

Litigation Update: Zofran MDL Set to Start in the Fall

Litigation Update: Zofran MDL Set to Start in the Fall

U.S. District Judge F. Dennis Saylor IV, who is handling the first bellwether in the MDL that relates to Zofran, has announced the date of October 18th as the potential start of the trial. Plaintiffs allege that Zofran, a drug manufactured by GlaxoSmithKline to ease...